Clear Harbor Asset Management, LLC Organon & Co. Transaction History

Clear Harbor Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$31.66 - $38.9 $598,563 - $735,443	-18,906 Reduced 50.73%	18,362 $620,000
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $32,520 - $42,036	-1,068 Reduced 2.79%	37,268 $1.3 Million
Q4 2021 Jan 21, 2022	BUY	$28.67 - $37.13 $25,659 - $33,231	895 Added 2.39%	38,336 $1.17 Million
Q3 2021 Nov 03, 2021	BUY	$28.63 - $35.64 $131,096 - $163,195	4,579 Added 13.93%	37,441 $1.23 Million
Q2 2021 Aug 06, 2021	BUY	$28.45 - $38.0 $934,923 - $1.25 Million	32,862 New	32,862 $994,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.